Location History:
- Ehime, JP (2005)
- Matsuyama, JP (2010)
Company Filing History:
Years Active: 2005-2010
Title: Yoshi Yakushijin: Innovator in Lymphoma Research
Introduction
Yoshi Yakushijin is a notable inventor based in Matsuyama, Japan. He has made significant contributions to the field of cancer research, particularly in understanding non-Hodgkin's lymphoma. With a total of 2 patents, his work has the potential to impact diagnostic and therapeutic approaches in oncology.
Latest Patents
Yoshi Yakushijin's latest patents focus on lymphoma-associated molecules and their uses. The first patent provides isolated nucleic acid molecules, designated as BAL nucleic acid molecules, which are differentially expressed in non-Hodgkin's lymphoma. This invention also includes antisense nucleic acid molecules, recombinant expression vectors containing BAL nucleic acid molecules, and host cells that have been modified with these expression vectors. Additionally, it encompasses nonhuman transgenic animals where a BAL gene has been introduced or disrupted. The patent further details isolated BAL proteins, fusion proteins, antigenic peptides, and anti-BAL antibodies, along with diagnostic methods utilizing these compositions.
The second patent similarly addresses isolated nucleic acid molecules, again focusing on BAL nucleic acid molecules that are differentially expressed in non-Hodgkin's lymphoma. It includes the same components as the first patent, emphasizing the importance of these molecules in cancer research and potential therapeutic applications.
Career Highlights
Yoshi Yakushijin is affiliated with the Dana-Farber Cancer Institute Inc., where he continues to advance his research in lymphoma. His work is characterized by a commitment to understanding the molecular underpinnings of cancer, which is crucial for developing effective treatments.
Collaborations
Yoshi has collaborated with esteemed colleagues such as Margaret A. Shipp and Ricardo Aguiar. These collaborations enhance the depth and breadth of his research, contributing to the collective effort in cancer research.
Conclusion
Yoshi Yakushijin's innovative work in lymphoma research exemplifies the critical role of inventors in advancing medical science. His patents not only provide valuable insights into non-Hodgkin's lymphoma but also pave the way for future diagnostic and therapeutic advancements.